Overview
Christopher Bartley is a Psychiatrist practicing medicine in San Francisco, California.
His clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
He is actively involved in clinical research, co-authoring 20 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
401 Parnassus Ave, San Francisco, CA 94143
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Stanford Psychiatry Residency
Amit Etkin is a Psychiatrist practicing medicine in Palo Alto, California. Dr. Etkin is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Post-Traumatic Stress Disorder (PTSD), Major Depression, and Generalized Anxiety Disorder (GAD).
San Francisco VA Medical Center
Thomas Neylan is a Psychiatrist practicing medicine in San Francisco, California. Dr. Neylan is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Post-Traumatic Stress Disorder (PTSD), Dementia, Alzheimer's Disease, Traumatic Brain Injury, and Deep Brain Stimulation.
San Francisco VA Medical Center
Daniel Mathalon is a Psychiatrist practicing medicine in San Francisco, California. Dr. Mathalon is highly rated in 1 condition, according to our data. His clinical expertise encompasses Schizophrenia, Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder, and Post-Traumatic Stress Disorder (PTSD).
Frequently Asked Questions about Dr. Christopher Bartley
How do I make an appointment with Dr. Christopher Bartley?
You can book an appointment with Dr. Christopher Bartley by calling their office at 415-353-9111. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Christopher Bartley a top-rated expert for Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christopher Bartley is classified as an Experienced expert for Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Christopher Bartley specialize in?
While Dr. Christopher Bartley is a Psychiatry, they have specific expertise in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.
Does Dr. Christopher Bartley participate in research or clinical trials?
Yes. Dr. Christopher Bartley has published 20 articles and abstracts on conditions like Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). You can view a list of Dr. Christopher Bartley's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Christopher Bartley accept my insurance?
Dr. Christopher Bartley accepts most major insurance plans, including Humana. We recommend calling the office directly at 415-353-9111 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)